Search Results

(S)-Tedizolid 50mg 50mg  | Purity Not Available

Adooq Bioscience

Torezolid is an oxazolidinone drug in phase-II clinical trials for complicated skin and skin-structure infections (cSSSI), including those caused by Methicillin-resistant Staphylococcus aureus (MRSA).

More Information Supplier Page

(S)-Tedizolid 5mg 5mg  | Purity Not Available

Adooq Bioscience

Torezolid is an oxazolidinone drug in phase-II clinical trials for complicated skin and skin-structure infections (cSSSI), including those caused by Methicillin-resistant Staphylococcus aureus (MRSA).

More Information Supplier Page

(S)-Tedizolid 10mg 10mg  | Purity Not Available

Adooq Bioscience

Torezolid is an oxazolidinone drug in phase-II clinical trials for complicated skin and skin-structure infections (cSSSI), including those caused by Methicillin-resistant Staphylococcus aureus (MRSA).

More Information Supplier Page

1alpha-Hydroxy VD4 1mg 1mg  | Purity Not Available

Adooq Bioscience

1alpha-Hydroxy VD4 , a 1alpha(OH)D derivative, can effectively induce the differentiation of monoblastic leukaemia U937, P39/TSU and P31/FUJ cells.

More Information Supplier Page